Shanghai, July 6, 2026 — Jiahui International Cancer Center (JICC) announced that a 59-year-old male patient from New Zealand has successfully finished T-cell apheresis for Satricabtagene autoleucel (CT041). This marks the first international patient to complete T-cell collection in China for the world’s first approved solid tumor CAR-T therapy, demonstrating China’s global competitiveness in translational cell therapy and showcasing Chinese innovative treatments to global pa

A major new medical policy has arrived! Personalized mRNA cancer vaccines are now available for 6 types of digestive system tumors, including pancreatic, liver, gastric, and colorectal cancer. This tailored vaccine trains your immune system to target residual cancer cells, greatly lowering recurrence risk and extending survival. Important: eligibility must be confirmed BEFORE surgery, as fresh tumor tissue is required for vaccine development. Don’t miss this life-changing opp